Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Kangpu Biopharmaceuticals Initiates Phase Ib/IIa Clinical Trial of KPG-818 in Systemic Lupus Erythematosus
2020-11-17 09:00
Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases
2020-11-17 01:09
Covis Group Completes Acquisition of AMAG Pharmaceuticals
2020-11-16 22:43
Harbour BioMed Will Present Results From Its Phase II Clinical Trial with Tanfanercept (HBM9036) in Patients with Moderate-to-Severe Dry Eye Disease in China at the 25th Congress of Chinese Ophthalmological Society
2020-11-16 20:17
INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense
2020-11-16 20:00
Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology
2020-11-16 08:00
CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
2020-11-14 01:03
The fourth CIIE begins taking stall reservations from exhibitors
2020-11-13 21:00
AlpVision to offer free of charge security feature to protect COVID-19 relevant medicines against counterfeiting
2020-11-13 20:25
Ascensia Diabetes Care Showcases The Crucial Support Nurses Provide People With Diabetes To Celebrate World Diabetes Day 2020
2020-11-13 14:00
Molecular Stethoscope Announces Completion of its NAFLD/NASH Study and Podium Presentation of Results by Dr. Naga Chalasani at the AASLD Liver Meeting 2020
2020-11-13 04:19
Connect Biopharma Announces Appointment of Karen J. Wilson and Dr. Kleanthis G. Xanthopoulos to Board of Directors
2020-11-12 21:00
XJTLU launches new Academy of Pharmacy
2020-11-12 15:13
The IDAI Immunization Task Force Sets Priorities for Covid-19 Vaccine Emergency Use
2020-11-11 12:51
Holmusk partners with Merck to help improve outcomes for Diabetes & Prediabetes patients in Asia-Pacific
2020-11-11 10:00
Innovation Drives Excellence, Innovent Successfully Held 2020 Virtual R&D Day
2020-11-11 08:00
Innovent Releases Phase 1a Results of CD47 Monoclonal Antibody (Letaplimab) in Monotherapy for Advanced Malignancies at SITC 2020
2020-11-11 08:00
FibroGenesis Announces the Filing of its 250th Patent for Fibroblast Cell Therapy Platform
2020-11-10 22:37
Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen
2020-11-10 09:00
Merck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics
2020-11-09 21:00
1
144
145
146
147
148
234